Gulkas Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-07-2024
- Paid Up Capital ₹ 0.99 M
as on 30-07-2024
- Company Age 34 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.01 Cr
as on 30-07-2024
- Satisfied Charges ₹ 6.93 M
as on 30-07-2024
- Revenue 22.84%
(FY 2023)
- Profit 17.54%
(FY 2023)
- Ebitda 9.88%
(FY 2023)
- Net Worth 13.56%
(FY 2023)
- Total Assets 0.45%
(FY 2023)
About Gulkas Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.99 M.
The company currently has active open charges totaling ₹1.01 Cr. The company has closed loans amounting to ₹6.93 M, as per Ministry of Corporate Affairs (MCA) records.
Gulamabbas Kadiwala, Kasamali Charolia, Hasanabbas Kadiwala, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ1990PTC014826
- Company No.
014826
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Gulkas Pharma Pvt Ltd offer?
Gulkas Pharma Pvt Ltd offers a wide range of products and services, including Flavours & Aromatics, Food Preservative, Construction Chemical, Calcium Chloride, Inorganic Salts, Sodium Chloride NaCl, Sodium Citrate, Chemical Reagents & Catalysts, Fertilizers and Soil Additives, Potassic Fertilizers.
Who are the key members and board of directors at Gulkas Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gulamabbas Kadiwala  | Director | 28-Dec-1990 | Current |
| Kasamali Charolia | Director | 28-Dec-1990 | Current |
| Hasanabbas Kadiwala | Director | 15-Oct-2003 | Current |
| Zulfikarali Charolia | Director | 25-Nov-2003 | Current |
Financial Performance of Gulkas Pharma.
Gulkas Pharma Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 22.84% increase. The company also saw a substantial improvement in profitability, with a 17.54% increase in profit. The company's net worth Soared by an impressive increase of 13.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gulkas Pharma?
In 2023, Gulkas Pharma had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.14 M
₹6.93 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.00 Cr
- State Bank Of Saurashtra : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2019 | Axis Bank Limited | ₹1.00 Cr | Open |
| 24 Oct 1990 | State Bank Of Saurashtra | ₹0.14 M | Open |
| 21 Nov 2005 | Sidbi | ₹2.65 M | Satisfied |
| 21 Nov 2005 | Sidbi | ₹2.65 M | Satisfied |
| 10 May 1997 | State Bank Of Saurashtra | ₹0.80 M | Satisfied |
How Many Employees Work at Gulkas Pharma?
Unlock and access historical data on people associated with Gulkas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gulkas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gulkas Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.